Authors' Reports
Hui-Ling Yeh
describes for SIIC the most significant aspects of his article
describe para SIIC los aspectos relevantes de su artículo

The role of postoperative chemoradiotherapy in the local control and overall survival of locally advanced esophageal squamous cell carcinoma
POSTOPERATIVE CHEMORADIOTHERAPY IN ESOPHAGEAL SQUAMOUS CARCINOMA

Our study presented a relatively good local control of the disease by the addition of postoperative chemoradiotherapy to locally advanced esophageal squamous cell carcinoma with a mild, acute treatment-related toxicity, but this did not contribute a higher survival rate for this group of patients.

The article was published by
El artículo fue publicado por
Formosan Journal of Surgery
Volume / Volumen: 45
Number / Número: 6
First and last pages / Páginas inicial-final: 172-177
Year / Año: 2012
Month / Mes: december


This journal, which is covered by SIIC Data Bases,
is part of the bibliographic collections of the Biblioteca Biomédica (BB) SIIC.
Esta revista, clasificada por SIIC Data Bases,
integra el acervo bibliográfico de la Biblioteca Biomédica (BB) SIIC.
icopagok.gif


Principal institution where the research took place
Institución principal de la investigación
Taichung Veterans General Hospital, Taichung City, Taichung, Taiwan


a-livro3.gif
Author's Report

Crónica del Autor


Bibliographic references
Referencias bibliográficas

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305-313.
3. Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg. 2003;75:331-336.
4. Yeh Hui-Ling, Hsu Chung-Ping, Lin Jin-Ching, et al. Clinical outcome of postoperative intensity-modulated radiotherapy for esophageal cancer. Therapeut Radiol Oncol. 2008;15: 269-278.
5. Rice TW, Adelstein DJ, Chidel MA, et al. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg. 2003;126:1590-1596.
6. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725-730.
7. AJCC Cancer Staging Manual. 7th ed. 2009.
8. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
9. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323-329.
10. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (Radiation Therapy Oncology group, RTOG 85-01). JAMA. 1999;281:1623-1627.
11. Tachibana M, Yoshimura H, Kinugasa S, et al. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Euro J Surg Oncol. 2003;29:580-587.
12. Adelstein DJ, Rice TW, Rybicki LA, et al. A Phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity. Am J Clin
Oncol. 2007;30:172-180.
13. Hofstetter W, Swisher SG, Correa AM, et al. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002;236: 376-385.
14. Hsu CP, Chen CY, Hsia JY, Shai SE. Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of thoracic esophagus. Eur J Cardiothorac Surg. 2001;19:10-13.
15. Kofoed SC, Muhic A, Baeksgaard L, et al. Survival after adjuvant chemoradiotherapy or Surgery alone in resectable adenocarcinoma at the gastro-esophageal junction. Scand J Surg. 2012;101:26-31.
16. Adelstein DJ, Rice TW, Rybicki LA, et al. Mature results from a phase ii trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol. 2009;4:1264-1269.

Other articles written by the author Hui-Ling Yeh
Otros artículos de Hui-Ling Yeh

{ otros articulos }




SIIC System of Assisted Editing (SSEA)
/ Sistema SIIC de Edición Asistida (SSEA)

Hui-Ling Yeh was invited by SIIC on
Hui-Ling Yeh fue invitado por SIIC el
2013, december 19
  The author's report was accepted on
La crónica del autor fue aprobada el
2017, may 11
The author's report was accepted on
La crónica del autor fue aprobada el
2017, may 11
Published in siicsalud
Publicado en siicsalud
2017, august 9





The article is strictly related to the following sections of siicsalud
El artículo se relaciona estrictamente con las siguientes secciones de siicsalud

 
Gastroenterology
/ Gastroenterología
 
Oncology
/ Oncología
 

and secondarily related to the following sections

y secundariamente con las siguientes secciones

Family Medicine
Medicina Familiar

Haematology
Hematología

Medical Education
Educación Médica

Surgery
Cirugía

Information about the full text
Acerca del trabajo completo


POSTOPERATIVE CHEMORADIOTHERAPY IN ESOPHAGEAL SQUAMOUS CARCINOMA


Author / Autor
Hui-Ling Yeh1

1 Dr., Department Of Radiation Oncology, Taichung Veterans General Hospital, Taichung City, Taiwán (Republica Nacionalista China), Attending Physcian


Access to the original source
Formosan Journal of Surgery

Article URL:
/ URL del artículo:
{ linkurl } { url }

URL of Abstract:
/ URL del abstract:
{ linkurlabs } { urlabs }

URL of Abstract page in Medline:
/ URL del abstract en Medline:
{ linkurlmed } { urlmed }

URL of Abstract page in Scielo:
/ URL del abstract en Scielo:
{ linkurlscielo } { urlscielo }

URL of Abstract page in Scopus:
/ URL del abstract en Scopus:
{ linkurlscopus } { urlscopus }

URL of Abstract page in Embase:
/ URL del abstract en Embase:
{ linkurlembase } { urlembase }

Other data bases:
/ Otras bases de datos:
{ linkurlotra } { urlotra }

siic DB:
/ siic DB:
http://www.siicsalud.com/dato/croin.php/139675

Bienvenidos a siicsalud

Acerca de SIIC     Estructura de SIIC



Sociedad Iberoamericana de Información Científica (SIIC)
Av. Belgrano 430, (C1092AAR), ciudad de Buenos Aires, Argentina
Tel: +54 11 4342 4901
Casilla de Correo 2568, (C1000WAZ) Correo Central, ciudad de Buenos Aires
Copyright siicsalud© 1997-2017, Sociedad  Iberoamericana de Información Científica (SIIC)
ISSN siicsalud: 1667-9008
ua4711
Mensajes a SIIC